Zymtronix
Ithaca
About Zymtronix
Zymtronix develops technology for enzyme immobilization. It provides a platform to immobilize enzymes and screen for immobilized enzyme performance, the unlocked potential of oxidative enzymes for biocatalysis, and new materials and customer-oriented processes for small molecule conversion. The company is optimizing enzyme immobilization to create unique, and sustainable and responsible processes for high-performance biocatalysis. Stéphane Corgié founded Zymtronix in 2013. It has its headquarters in Ithaca in New York.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.9M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Dec 2021)
- Website: zymtronix.com
- Phone: 607-351-2639
Industries & Categories
Biotechnology, Genetics, Life Science, Product Research
Social Profiles
Canonical: https://fsome.com/organization/zymtronix-60953 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.